Status:
TERMINATED
Study of DERMABOND ProPen in Closure of Colectomy Wounds
Lead Sponsor:
Singapore General Hospital
Conditions:
Wound
Eligibility:
All Genders
21+ years
Phase:
PHASE2
Brief Summary
2-octylcyanoacrylate (2-OCA) has been used extensively in clinical practice in trauma, plastic surgery, orthopaedic surgery, emergency medicine and paediatrics. Most studies on 2-OCA to date have focu...
Eligibility Criteria
Inclusion
- Patients undergoing elective colectomies for benign or malignant conditions
- Midline vertical incisions or skin crease incisions
- Above the age of 21 years old
- Able to make own valid informed decisions
Exclusion
- Patients undergoing surgery for recurrent or metastatic disease
- Surgery for surgical emergencies such as acute abdomen or bleeding
- Known allergy to DERMABOND ProPen Tissue Adhesive or any of its constituents (cyanoacrylate or formaldehyde)
- Patients on immunosuppression
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT00978133
Start Date
May 1 2006
End Date
May 1 2007
Last Update
April 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore General Hospital
Singapore, Singapore, 169608